{"date": "2018-01-17_21:27:40", "url": "http://www.eurekalert.org/pub_releases/2017-02/mgh-cts022717.php", "year": "Mon, 27 Feb 2017 05:00:00 GMT", "text": ["experimental", "biology", "2017april", "22", "26", "2017chicago", "il2018", "aaas", "annual", "meeting", "february", "15", "19", "2018austin", "txa", "clinical", "trial", "new", "drug", "prevent", "attacks", "hereditary", "angioedema", "hae", "rare", "disorder", "characterized", "recurrent", "swelling", "tissues", "face", "hands", "gastrointestinal", "tract", "airway", "promising", "results", "february", "23", "new", "england", "journal", "medicine", "team", "describes", "subcutaneous", "injection", "monoclonal", "antibody", "lanadelumab", "every", "14", "days", "significantly", "reduced", "swelling", "episodes", "without", "serious", "side", "effects", "hae", "patients", "study", "found", "lanadelumab", "appears", "safe", "well", "tolerated", "hae", "patients", "early", "data", "small", "number", "patients", "suggests", "strong", "efficacy", "says", "aleena", "banerji", "md", "massachusetts", "general", "hospital", "mgh", "division", "rheumatology", "allergy", "immunology", "corresponding", "lead", "author", "nejm", "publication", "larger", "phase", "3", "study", "evaluate", "efficacy", "lanadelumab", "underway", "hae", "caused", "mutations", "reduce", "production", "expression", "c1", "inhibitor", "protein", "enzyme", "inhibits", "activity", "proteins", "involved", "inflammatory", "blood", "coagulation", "systems", "without", "action", "c1", "inhibitor", "protein", "cascade", "inhibited", "leading", "excess", "generation", "bradykinin", "causes", "vascular", "leakage", "responsible", "swelling", "seen", "hae", "patients", "uncontrolled", "swelling", "resulting", "hae", "attacks", "restricts", "activities", "patients", "sometimes", "several", "days", "also", "airway", "involved", "treatment", "administered", "attack", "essential", "preventing", "attacks", "would", "beneficial", "many", "patients", "however", "currently", "preventive", "therapies", "limitations", "attenuated", "androgens", "significant", "side", "effects", "safe", "pregnancy", "intravenous", "c1", "inhibitor", "often", "inconvenient", "needs", "administered", "every", "three", "four", "nejm", "publication", "reports", "phase", "1b", "clinical", "trial", "lanadelumab", "monoclonal", "antibody", "inhibits", "action", "kallikrein", "potentially", "blocking", "cascade", "leading", "bradykinin", "generation", "study", "enrolled", "37", "patients", "hae", "resulting", "c1", "inhibitor", "deficiency", "divided", "five", "groups", "four", "groups", "received", "two", "subcutaneous", "injections", "lanadelumab", "14", "days", "apart", "total", "dosages", "30", "mg", "100", "mg", "300", "mg", "400", "mg", "group", "received", "injections", "placebo", "participants", "followed", "120", "days", "second", "injection", "occurrence", "adverse", "events", "related", "treatment", "primarily", "pain", "injection", "site", "headache", "similar", "across", "groups", "serious", "events", "reported", "supporting", "safety", "treatment", "participants", "receiving", "doses", "totaling", "300", "mg", "400", "mg", "action", "kallikrein", "found", "inhibited", "manner", "participants", "average", "two", "hae", "attacks", "three", "months", "prior", "enrollment", "efficacy", "evaluated", "300", "mg", "400", "mg", "groups", "period", "day", "8", "day", "50", "initial", "injection", "none", "five", "participants", "receiving", "300", "mg", "two", "eleven", "receiving", "400", "mg", "attack", "contrast", "eight", "eleven", "patients", "placebo", "group", "hae", "attacks", "period", "kind", "efficacy", "seen", "larger", "phase", "3", "trial", "underway", "mgh", "many", "sites", "could", "significantly", "improve", "quality", "life", "patients", "hae", "says", "banerji", "associate", "professor", "medicine", "harvard", "medical", "school", "author", "nejm", "paper", "paula", "busse", "md", "icahn", "school", "medicine", "mt", "sinai", "new", "york", "study", "supported", "dyax", "developer", "lanadelumab", "part", "shire", "mgh", "clinical", "research", "center", "supported", "national", "institutes", "health", "grant", "1ul1"], "title": "Clinical trial supports use of novel preventive therapy for dangerous swelling disorder | EurekAlert! Science News", "source": "Massachusetts General Hospital"}